Vivani Stock Based Compensation To Revenue from 2010 to 2025
| VANI Stock | USD 1.35 0.04 2.88% |
Stock Based Compensation To Revenue | First Reported 2010-12-31 | Previous Quarter 0.55 | Current Value 0.59 | Quarterly Volatility 0.12686882 |
Check Vivani Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vivani Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 408.7 K, Interest Expense of 8.9 M or Selling General Administrative of 7.9 M, as well as many indicators such as Price To Sales Ratio of 89.89, Dividend Yield of 0.0 or PTB Ratio of 3.8. Vivani financial statements analysis is a perfect complement when working with Vivani Medical Valuation or Volatility modules.
Vivani | Stock Based Compensation To Revenue | Build AI portfolio with Vivani Stock |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out the analysis of Vivani Medical Correlation against competitors. For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vivani Medical is measured differently than its book value, which is the value of Vivani that is recorded on the company's balance sheet. Investors also form their own opinion of Vivani Medical's value that differs from its market value or its book value, called intrinsic value, which is Vivani Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivani Medical's market value can be influenced by many factors that don't directly affect Vivani Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivani Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.